CG Health Ventures Overview

CG Health Ventures is a Barcelona-based venture capital firm founded in 2015 by Carlos Gallardo. The firm focuses on early-stage investments in healthcare technology, digital health, and genomics companies across Europe and the United States. They provide capital, sector expertise, and operational support to management teams, aiming to help companies scale globally. Since 2014, they have backed the growth of numerous healthcare businesses across geographies.

Is CG Health Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with CG Health Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.

CG Health Ventures

VC Fund

Investment focus

Invest in

  • Baltics
  • Nordics
  • Western Europe
  • Southern Europe
  • Central Eastern Europe
  • Caribbean
View all

Industries / verticals

  • BioTech & Life Sciences
  • Digital & Consumer health
  • Health Data, Healthcare Systems & Infrastructure

Investment role

Lead and follow

Stages

Seed, Series A

First ticket size

€1,500,000 - €3,000,000

How to approach funds like CG Health Ventures

When reaching out to CG Health Ventures, founders should highlight how their solution addresses significant unmet needs in healthcare and demonstrate a clear path to global scalability. Emphasize strong clinical validation, regulatory strategy, and a robust go-to-market plan, as the team values operational excellence and sector expertise. Articulate how your technology or platform can drive measurable impact in patient outcomes or healthcare delivery, and be prepared to discuss traction in both European and U.S. markets.

Find the best-fitting investors for your startup

Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.

Find your investor matches
Investor funnel board

Check the next investor profile